Nilstat and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take Nilstat (nystatin), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Prednisolone, and have Urinary tract infection.

The study is created by eHealthMe based on reports of 488 people who have side effects when taking Nilstat from the FDA, and is updated regularly.

What is Nilstat?

Nilstat has active ingredients of nystatin. eHealthMe is studying from 498 Nilstat users. Check the latest studies of Nilstat.

On Jul, 14, 2026

488 people reported to have side effects when taking Nilstat.
Among them, 12 people (2.46%) died.

Among these 12 people:

How long have people been on Nilstat when they died? *

What is the gender of people who died when taking Nilstat? *

female: 58.33 %
male: 41.67 %

What is the age of people who died when taking Nilstat? *

What are other drugs people take besides Nilstat? *

What are other side effects people have before they died? *

Urinary Tract Infection: 3 people, 25.00%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 25.00%
Hepatic Enzyme Increased: 2 people, 16.67%
Haematocrit Decreased: 2 people, 16.67%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 16.67%
Red Blood Cell Count Decreased: 2 people, 16.67%
Oxygen Saturation Decreased: 2 people, 16.67%
Nausea (feeling of having an urge to vomit): 2 people, 16.67%
Swallowing Difficulty: 2 people, 16.67%
Respiratory Depression (respiration has a rate below 12 breaths): 2 people, 16.67%

What are the existing conditions these people have? *

Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream): 3 people, 25.00%
Oral Candidiasis (fungal infection of mouth): 3 people, 25.00%
Anaemia (lack of blood): 3 people, 25.00%
Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 25.00%
Depression: 3 people, 25.00%
Diarrhea: 3 people, 25.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 25.00%
Infusion Related Reaction: 3 people, 25.00%
Muscle Spasms (muscle contraction): 3 people, 25.00%
Urinary Tract Infection: 3 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nilstat:

Nilstat (498 reports)

Expand to all the drugs that have ingredients of nystatin:

Death and drugs with ingredients of nystatin (1,533 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nilstat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,127 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nystatin (the active ingredients of Nilstat) and Nilstat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.